NO994330L - Metode for behandling av en tumor - Google Patents

Metode for behandling av en tumor

Info

Publication number: NO994330L
Authority: NO; Norway
Prior art keywords: mammal; administering; effective amount; tumor; treating
Prior art date: 1997-03-07

Application number

NO994330A

Other languages

English (en)

Other versions

NO994330D0 (no

NO324974B1 (no

Inventor

Daniel L Dexter

Paul E Juniewicz

James B Rake

Daniel D Von Hoff

Original Assignee

Sanofi Winthrop Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-03-07

Filing date

1999-09-06

Publication date

1999-10-25

1999-09-06 Application filed by Sanofi Winthrop Inc filed Critical Sanofi Winthrop Inc

1999-09-06 Publication of NO994330D0 publication Critical patent/NO994330D0/no

1999-10-25 Publication of NO994330L publication Critical patent/NO994330L/no

2008-01-14 Publication of NO324974B1 publication Critical patent/NO324974B1/no

Links

206010028980 Neoplasm Diseases 0.000 title abstract 3
241000124008 Mammalia Species 0.000 abstract 4
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 4
229930012538 Paclitaxel Natural products 0.000 abstract 2
229960001592 paclitaxel Drugs 0.000 abstract 2
229910052697 platinum Inorganic materials 0.000 abstract 2
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 2
230000002195 synergetic effect Effects 0.000 abstract 1
ORYDPOVDJJZGHQ-UHFFFAOYSA-N tirapazamine Chemical compound C1=CC=CC2=[N+]([O-])C(N)=N[N+]([O-])=C21 ORYDPOVDJJZGHQ-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO19994330A 1997-03-07 1999-09-06 Anvendelse av 3-amino-1,2,4-benzotriazin-1,4-dioksyd/paclitaxel/platina for fremstilling av et preparat for behandling av et pattedyr som har en fast tumor samt kit inneholdende nevnte preparat. NO324974B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US81476997A	1997-03-07	1997-03-07
PCT/US1998/003292 WO1998039009A1 (en)	1997-03-07	1998-02-17	Method of treating a tumor

Publications (3)

Publication Number	Publication Date
NO994330D0 NO994330D0 (no)	1999-09-06
NO994330L true NO994330L (no)	1999-10-25
NO324974B1 NO324974B1 (no)	2008-01-14

Family

ID=25215967

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19994330A NO324974B1 (no)	1997-03-07	1999-09-06	Anvendelse av 3-amino-1,2,4-benzotriazin-1,4-dioksyd/paclitaxel/platina for fremstilling av et preparat for behandling av et pattedyr som har en fast tumor samt kit inneholdende nevnte preparat.

Country Status (15)

Country	Link
US (2)	US6063780A (no)
EP (1)	EP1014990B1 (no)
JP (1)	JP2001513110A (no)
AT (1)	ATE338553T1 (no)
AU (1)	AU6178198A (no)
BR (1)	BR9808221A (no)
CA (1)	CA2281807C (no)
DE (1)	DE69835824T2 (no)
DK (1)	DK1014990T3 (no)
ES (1)	ES2268764T3 (no)
HR (1)	HRP980095A2 (no)
NO (1)	NO324974B1 (no)
PT (1)	PT1014990E (no)
WO (1)	WO1998039009A1 (no)
ZA (1)	ZA981609B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1014990B1 (en) *	1997-03-07	2006-09-06	Sanofi-Aventis U.S. LLC	Antitumor combination of 3-amino-1,2,4-benzotriazine 1,4-dioxide/paclitaxel/platinum
DE69901725T2 (de)	1998-10-14	2003-01-30	Debiopharm S.A., Lausanne	Verpackung eines oxaliplatinhaltigen arzneimittels
DE19925211B4 (de) *	1999-06-01	2006-01-12	PBS Pharmaceutical Bulk Substances SA	Kit zur Herstellung einer Formulierung von Paclitaxel
CA2382389C (fr) *	1999-08-30	2010-06-29	Debiopharm S.A.	Preparation pharmaceutique stable d'oxaliplatine pour administration par voie parenterale
US7070796B1 (en)	1999-08-30	2006-07-04	Debiopharm S.A.	Pharmaceutically stable oxaliplatinum preparation for parenteral administration
US7012072B2 (en)	2000-12-12	2006-03-14	Debiopharm S.A.	Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same
US6476068B1 (en)	2001-12-06	2002-11-05	Pharmacia Italia, S.P.A.	Platinum derivative pharmaceutical formulations
WO2004012746A2 (en) *	2002-08-02	2004-02-12	The Regents Of The University Of California	New uses for inhibitors of inosine monophosphate dehydrogenase
EP1663153A4 (en) *	2003-05-20	2011-01-05	Aronex Pharmaceuticals Inc	COMBINATION SCHEMOTHERAPY WITH A LIPOSOMAL PLATINUM COMPLEX
US7989490B2 (en)	2004-06-02	2011-08-02	Cordis Corporation	Injectable formulations of taxanes for cad treatment
US20060275331A1 (en) *	2004-08-31	2006-12-07	Borek Zaludek	Pharmaceutical composition, method of manufacturing and therapeutic use thereof
JP2006248978A (ja)	2005-03-10	2006-09-21	Mebiopharm Co Ltd	新規なリポソーム製剤
JP2009510165A (ja) *	2005-10-03	2009-03-12	ジェネティックスファーマシューティカルズ，インク．	低酸素細胞を選択的に枯渇させるための方法
US20070212360A1 (en) *	2006-01-17	2007-09-13	Denko Nicholas C	Modulation of mitochondrial oxygen consumption for therapeutic purposes
US8026017B2 (en)	2007-03-16	2011-09-27	The United States Of America As Represented By The Secretary Of The Army	High voltage methanol fuel cell assembly using proton exchange membranes and base/acid electrolytes
CN102026634B (zh)	2008-04-10	2014-01-22	弗吉尼亚州立邦联大学	诱导肿瘤缺氧以治疗癌症
WO2014062856A1 (en)	2012-10-16	2014-04-24	Halozyme, Inc.	Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
EP4201403A1 (en) *	2021-12-21	2023-06-28	Som Innovation Biotech, S.L.	Compounds tirapazamine and quazinone for use in the treatment of gm2 gangliosidoses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5399363A (en) *	1991-01-25	1995-03-21	Eastman Kodak Company	Surface modified anticancer nanoparticles
US5484612A (en) *	1993-09-22	1996-01-16	The Board Of Trustees Of The Leland Stanford Junior University	Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
EP1014990B1 (en) *	1997-03-07	2006-09-06	Sanofi-Aventis U.S. LLC	Antitumor combination of 3-amino-1,2,4-benzotriazine 1,4-dioxide/paclitaxel/platinum

1998
- 1998-02-17 EP EP98906594A patent/EP1014990B1/en not_active Expired - Lifetime
- 1998-02-17 BR BR9808221-3A patent/BR9808221A/pt not_active Application Discontinuation
- 1998-02-17 CA CA002281807A patent/CA2281807C/en not_active Expired - Fee Related
- 1998-02-17 AU AU61781/98A patent/AU6178198A/en not_active Abandoned
- 1998-02-17 AT AT98906594T patent/ATE338553T1/de not_active IP Right Cessation
- 1998-02-17 ES ES98906594T patent/ES2268764T3/es not_active Expired - Lifetime
- 1998-02-17 DE DE69835824T patent/DE69835824T2/de not_active Expired - Fee Related
- 1998-02-17 JP JP53855198A patent/JP2001513110A/ja not_active Ceased
- 1998-02-17 PT PT98906594T patent/PT1014990E/pt unknown
- 1998-02-17 DK DK98906594T patent/DK1014990T3/da active
- 1998-02-17 WO PCT/US1998/003292 patent/WO1998039009A1/en not_active Ceased
- 1998-02-25 HR HR08/814,769A patent/HRP980095A2/hr not_active Application Discontinuation
- 1998-02-26 ZA ZA981609A patent/ZA981609B/xx unknown
- 1998-02-27 US US09/031,692 patent/US6063780A/en not_active Expired - Fee Related
1999
- 1999-09-06 NO NO19994330A patent/NO324974B1/no unknown
2000
- 2000-02-16 US US09/505,043 patent/US6319923B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US6063780A (en)	2000-05-16
NO994330D0 (no)	1999-09-06
AU6178198A (en)	1998-09-22
DE69835824T2 (de)	2007-03-29
BR9808221A (pt)	2000-05-16
JP2001513110A (ja)	2001-08-28
HRP980095A2 (en)	1998-12-31
PT1014990E (pt)	2006-11-30
EP1014990B1 (en)	2006-09-06
NO324974B1 (no)	2008-01-14
EP1014990A1 (en)	2000-07-05
ATE338553T1 (de)	2006-09-15
DE69835824D1 (de)	2006-10-19
US6319923B1 (en)	2001-11-20
ZA981609B (en)	1998-12-08
WO1998039009A1 (en)	1998-09-11
ES2268764T3 (es)	2007-03-16
CA2281807C (en)	2007-10-16
EP1014990A4 (en)	2004-03-24
CA2281807A1 (en)	1998-09-11
DK1014990T3 (da)	2006-12-11

Publication	Publication Date	Title
NO994330D0 (no)	1999-09-06	Metode for behandling av en tumor
DK1068870T3 (da)	2006-10-02	Antitumormidler
PT882021E (pt)	2003-07-31	Novas fenantridinas
FI972086A7 (fi)	1997-05-15	Parannetun monilääkeresistenssiaktiivisuuden omaavat uudet aminohappoj ohdokset
ATE386808T1 (de)	2008-03-15	Arzneimittelzubereitungen für die behandlung von alpha-galactosidase a-mangel
ATE207355T1 (de)	2001-11-15	Behandlung von hyperproliferativen gefässerkrankungen
DE69433889D1 (de)	2004-08-12	Anwendung von 1,2,4-benzotriazinoxiden zur Herstellung eines Arzneimittels zur Behandlung von Tumoren
PT880350E (pt)	2002-04-29	Tratamento de esclerose multipla
DE69807349D1 (de)	2002-09-26	Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren
ATE258796T1 (de)	2004-02-15	Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
PT902789E (pt)	2002-07-31	Derivados de androsteno
BG100510A (bg)	1996-11-29	Метод за лечение на андрогенна алопеция с инхибитори на 5-алфа редуктаза
PL340679A1 (en)	2001-02-12	Application of a mixture of diole and alpha-hydroxyacid in treating
EA200000242A1 (ru)	2000-08-28	Применение фанхинона для лечения болезни альцгеймера
ATE281841T1 (de)	2004-11-15	Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
DE69612056D1 (de)	2001-04-19	Terpenderivate (sarcodictyine) als antikrebsmittel
ATE317263T1 (de)	2006-02-15	Diphosphonat derivate von therapeutisch wirksamen stoffen
ATE204476T1 (de)	2001-09-15	Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
DE69814691D1 (de)	2003-06-18	Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
LV11593A (lv)	1996-12-20	Dimetikona pielietojums aizcietejumu arstesana
RU94024337A (ru)	1996-05-10	Антиметастатическое средство
DE69426986D1 (de)	2001-05-03	Behandlung von laminitis
ATE271867T1 (de)	2004-08-15	Behandlung der harninkontinenz und zusammenstellung dafür
DE69635282D1 (de)	2006-02-23	Behandlung der exzessiven aggressivität mit olanzapine